(23 days)
Not Found
No
The summary describes a pulse oximetry sensor and cable system, focusing on hardware design and compatibility with existing monitors. There is no mention of AI, ML, or any software algorithms that would suggest the use of such technologies for data processing or interpretation. The performance studies focus on standard accuracy metrics for SpO2 measurement.
No
The device is described as an oximetry sensor intended for continuous monitoring of functional oxygen saturation, which is a diagnostic function, not a therapeutic one. It measures a physiological parameter but does not directly treat or prevent a medical condition.
Yes
The device is indicated for "continuous monitoring of functional oxygen saturation", which involves measuring physiological parameters to assess a patient's health status. This falls under the definition of a diagnostic device.
No
The device description explicitly details physical hardware components, including sensors (emitters and detectors), cables, and adhesive bandages, which are integral to its function. It is not solely software.
Based on the provided information, this device is not an In Vitro Diagnostic (IVD).
Here's why:
- IVDs analyze samples taken from the human body. The intended use and device description clearly state that the LNCS Sensors and Cables are used for the continuous monitoring of physiological parameters (oxygen saturation and pulse rate) on the patient's body (fingers, toe, ear). They do not involve the analysis of biological samples like blood, urine, or tissue.
- The device measures physiological signals directly. The description mentions emitters and detectors that interact with the patient's body to measure light absorption, which is then used to calculate oxygen saturation and pulse rate. This is a direct physiological measurement, not an in vitro analysis.
Therefore, the LNCS Sensors and Cables fall under the category of in vivo diagnostic devices or patient monitoring devices, not In Vitro Diagnostics.
N/A
Intended Use / Indications for Use
The LNCS Sensors and Cables are indicated for the continuous nonitoring of functional oxygen saturation I he LNCS Sellsons and Cables are multided for and continued by an SpO2 sensor) for use with adult, pediatric, infant, and of arterial nemogroum (op(0)) and pare (motion conditions, and for patients who are well or poorly perfused in hospitals, hospital-type facilities, mobile, and home environments.
Product codes
74DQA, 74DSA, 74DPZ
Device Description
The LNCS Oximetry Sensors are fully compatible disposable and reusable sensors for use with Masimo SET compatible pulse oximeter monitors. They represent a design change to the Masimo LNOP Oximetry Sensors.
The LNCS DC-I/DC-IP reusable sensors are essentially identical to Masimo LNOP-DC-I/DC-IP sensors except for the connector at the end of the cable which interfaces with the LNCS patient cable. The emitter and detector are mounted in opposing halves of the molded clothespin style sensor with contoured pads to maintain contact with the patient's fingers. The same emitter (with Red wavelength of 658 nm and Infrared wavelength of 905 nm) and detector are used in both the LNCS DC-I/DC-IP and LNOP-DC-I/DC-IP sensors. The patient contacting materials in the LNCS DC-I/DC-IP and LNOP-DC-IP sensors are the same. The LNCS DC-I/DC-IP sensors are supplied non-sterile.
The LNCS TC-I and TF-I reusable sensors are essentially identical to Masimo LNOP-Ear and TF-I sensors except for the connector at the end of the cable which interfaces with the LNCS patient cable. The same emitter (with Red wavelength of 653/659 nm and Infrared wavelength of 880 nm respectively) and detector are used in both the LNCS TC-I and TF-I and LNOP- Ear and TF-I sensors. The patient contacting materials in the LNCS TC-I and TF-I and LNOP- Ear and TF-I sensors are the same. The LNCS TC-I and TF-I sensors are supplied non-sterile.
The LNCS disposable sensors are similar in construction to the predicate devices except that the LNCS sensors are cable based while the LNOP sensors are flex circuit based. The emitter and detector are connected to the cable assembly. The sensors have an adhesive bandage to allow the sensor to be attached to the patient's finger or toe. The same emitter (with Red wavelength of 658 nm and Infrared wavelength of 905 nm) is used in Masimo's LNOP series of disposable sensors. Four sizes of disposable LNCS sensors are available for use with adult, pediatric, infant and neonatal patients. The four sensors are essentially identical except for the emitter and detector spacing and size and orientation of the bandage material. The patient contacting materials in the LNCS disposable sensors are the same that is used in Masimo's LNOP sensor line. The LNCS disposable sensors are supplied non-sterile for single patient use.
The LNCS patient cables are similar in construction to the predicate device enabling the LNCS Oximetry Sensors to be connected to Masimo and Masimo compatible pulse oximeter monitors.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Non-invasive optical assessment of tissue oxygenation
Anatomical Site
Patient's fingers or toe, Ear
Indicated Patient Age Range
Adult, pediatric, infant, and neonatal patients
Intended User / Care Setting
Hospitals, hospital-type facilities, mobile, and home environments.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Clinical studies were performed using the LNCS Disposable and Reusable oximetry sensors on healthy adult volunteer subjects during motion and no motion conditions who were subjected to a progressive induced hypoxia and measuring the arterial hemoglobin saturation value with the instruments against the arterial hemoglobin oxygen determined from arterial blood samples with a CO-Oximeter.
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Biocompatibility: All patient contacting materials used in the LNCS sensors are the same materials used in Masimo's LNOP series of sensors. Test results demonstrated that the materials were non-toxic, non-irritating, and non sensitizing.
Environmental Testing: Applicable environmental testing per the Reviewers Guidance for Premarket Submissions - November 1993, i.e. electrical, mechanical and environmental were performed and all tests passed.
Clinical Testing: Clinical testing of the SPO2.COM Disposable and Reusable sensors resulted in an accuracy of less than 2% SpO2 ARMs in the range of 70%-100% SaO2 for adults, pediatrics and infants and less than 3% ARMs for neonates.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Accuracy: less than 2% SpO2 ARMs in the range of 70%-100% SaO2 for adults, pediatrics and infants and less than 3% ARMs for neonates.
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 870.2700 Oximeter.
(a)
Identification. An oximeter is a device used to transmit radiation at a known wavelength(s) through blood and to measure the blood oxygen saturation based on the amount of reflected or scattered radiation. It may be used alone or in conjunction with a fiberoptic oximeter catheter.(b)
Classification. Class II (performance standards).
0
JUL 2 9 2004
510(k) SUMMARY
Image /page/0/Picture/2 description: The image shows the logo for Masimo, a medical technology company. The logo is in black and white and features the company name in a bold, sans-serif font. Below the logo is the company's address, which is 40 Parker, Irvine, CA 92618, and their phone number, which is 949-297-7000.
| Submitted by: | Masimo Corporation
40 Parker
Irvine, CA 92618
949-297-7000
FAX 949-297-7001 |
|---------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Company Contact: | James J. Cronin, Vice President, Regulatory Affairs/Quality Assurance |
| Date Summary Prepared: | July 2, 2004 |
| Trade Name | LNCS Oximetry Sensors |
| Common Name | Oximeter Sensor |
| Classification Name and Product Code: | Oximeter (74DQA) (870.2700)
Cable, Transducer and Electrode (74DSA) (870.2900)
Oximeter, Ear (74DPZ) (870.2710) |
| Substantially Equivalent Devices: | Masimo SET® Radical Pulse Oximeter with SatShare™ and LNOP®
scries of Sensors and Cables
510(k) Number - K031330
Masimo SET Intellivue Pulse Oximeter Module
510(k) Number - K040259
SPO2.COM A, P, I, N, RS-I Pulse Oximeter Sensors
510(k) Number - K033298 |
Device Description
The LNCS Oximetry Sensors are fully compatible disposable and reusable sensors for use with Masimo SET compatible pulse oximeter monitors. They represent a design change to the Masimo LNOP Oximetry Sensors.
The LNCS DC-I/DC-IP reusable sensors are essentially identical to Masimo LNOP-DC-I/DC-IP sensors except for the connector at the end of the cable which interfaces with the LNCS patient cable. The emitter and detector are mounted in opposing halves of the molded clothespin style sensor with contoured pads to maintain contact with the patient's fingers. The same emitter (with Red wavelength of 658 nm and Infrared wavelength of 905 nm) and detector are used in both the LNCS DC-I/DC-IP and LNOP-DC-I/DC-IP sensors. The patient contacting materials in the LNCS DC-I/DC-IP and LNOP-DC-IP sensors are the same. The LNCS DC-I/DC-IP sensors are supplied non-sterile.
The LNCS TC-I and TF-I reusable sensors are essentially identical to Masimo LNOP-Ear and TF-I sensors except for the connector at the end of the cable which interfaces with the LNCS patient cable. The same emitter (with Red wavelength of 653/659 nm and Infrared wavelength of 880 nm respectively) and detector are used in
0305
1
510(k) SUMMARY
both the LNCS TC-I and TF-I and LNOP- Ear and TF-I sensors. The patient contacting materials in the LNCS TC-I and TF-I and LNOP- Ear and TF-I sensors are the same. The LNCS TC-I and TF-I sensors are supplied non-sterile.
The LNCS disposable sensors are similar in construction to the predicate devices except that the LNCS sensors are cable based while the LNOP sensors are flex circuit based. The emitter and detector are connected to the cable assembly. The sensors have an adhesive bandage to allow the sensor to be attached to the patient's finger or toe. The same emitter (with Red wavelength of 658 nm and Infrared wavelength of 905 nm) is used in Masimo's LNOP series of disposable sensors. Four sizes of disposable LNCS sensors are available for use with adult, pediatric, infant and neonatal patients. The four sensors are essentially identical except for the emitter and detector spacing and size and orientation of the bandage material. The patient contacting materials in the LNCS disposable sensors are the same that is used in Masimo's LNOP sensor line. The LNCS disposable sensors are supplied non-sterile for single patient use.
The LNCS patient cables are similar in construction to the predicate device enabling the LNCS Oximetry Sensors to be connected to Masimo and Masimo compatible pulse oximeter monitors.
| LNCS Sensor Line | Masimo Predicate LNOP Sensors
- in K031330, K040259 |
|-------------------------------------------------------|--------------------------------------------------------|
| LNCS DC-I/DC-IP - Reusable Adult/Pediatric
Sensors | LNOP-DC-I/DC-IP |
| LNCS Adt - Adult Disposable Sensor | LNOP-Adt |
| LNCS Pdt - Pediatric DisposableSensor | LNOP- Pdt |
| LNCS Inf - Infant Disposable Sensor | LNOP-Neo |
| LNCS Neo - Neonatal Disposable Sensor | LNOP-Neo |
| LNCS NeoPt - Neonatal Disposable Sensor | LNOP NeoPt |
| LNC 10 - Patient Cable | PC Patient Cable |
| LNC to PC | N/A |
| LNC to Intellivue | MP12 |
| LNCS TC-I- Reusable Ear Sensor | LNOP Ear |
| LNCS TF-I - Reusable Transflectance Sensor | LNOP-TF-I |
Predicate Devices
Intended Use
The LNCS oximetry sensors and cables are intended for the continuous nonitoring of functional oxygen saturation of arterial hemoglobin (SpO2) and pulse rate (measured by an SpO2 sensor) for adult, pediatric, infant, and neonatal patients in hospitals, hospital-type facilities, mobile, and home environments.
Technology Comparison
The LNCS oximetry sensors are substantially equivalent in intended use, design, principles of operation, materials, and performance to predicate sensors and operate on identical principles of non-invasive optical assessment of tissue oxygenation using emitters and detectors.
The LNCS oximetry sensors are designed, and manufactured for full compatibility with Masimo SET and Masimo SE i` compatible pulse oximeters. The LNCS oximetry sensors are constructed of similar materials and components of equivalent specifications as used in the predicate devices.
0300
The accuracy of the LNCS oximetry sensors is equivalent to those of the predicate devices.
Performance Testing
2
510(k) SUMMARY
Biocompatibility
All the patient contacting materials used in the LNCS sensors are the same materials that are used in Masimo's LNOP series of sensors. Test results demonstrated that the materials were non-toxic, non-irritating, and non sensitizing.
Environmental Testing
Applicable environmetal testing per the Reviewers Guidance for Premarket Submissions - November 1993, i.e. electrical, mechanical and environmental were performed and all tests passed
Clinical Testing
Clinical studies were performed using the LNCS Disposable and Reusable oximetry sensors on healthy adult volunteer subjects during motion and no motion conditions who were subjected to a progressive induced hypoxia and measuring the arterial hemoglobin saturation value with the instruments against the arterial hemoglobin oxygen determined from arterial blood samples with a CO-Oximeter. Clinical testing of the SPO2.COM Disposable and Reusable sensors resulted in an accuracy of less than 2% SpO2 ARMs in the range of 70%-100% SaO2 for adults, pediatrics and infants and less than 3% ARMs for neonates.
3
Image /page/3/Picture/1 description: The image is a black and white seal for the Department of Health & Human Services - USA. The seal is circular with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. In the center of the seal is an abstract symbol that resembles a bird or a stylized human figure.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
JUL 2 9 2004
Mr. James J. Cronin Vice President, Regulatory Affairs & Quality Assurance Masimo Corporation 40 Parker Irvine, California 92618
Re: K041815
Trade/Device Name: LNCS Oximetry Sensors Regulation Number: 21 CFR 870.2700 Regulation Name: Oximeter Regulatory Class: II Product Code: DQA Dated: July 2, 2004 Received: July 6, 2004
Dear Mr. Cronin:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
4
Page 2 - Mr. Cronin
Please be advised that FDA's issuance of a substantial equivalence determination does not I lease to act read a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. or the receiver with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice and ifsuing (21 es read in the quality systems (QS) regulation (21 CFR Part 820); and if requirences as bet resist product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) remarket notification. The FDA finding of substantial equivalence of your device to a premaired foredicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), 11 you donto the Office of Compliance at (301) 594-4646. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours,
Carls
Chiu Lin, Ph.D. Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
5
Indications for Use
510(k) Number (if known):
LNCS Sensors and Cables Device Name:
Indications For Use:
The LNCS Sensors and Cables are indicated for the continuous nonitoring of functional oxygen saturation I he LNCS Sellsons and Cables are multided for and continued by an SpO2 sensor) for use with adult, pediatric, infant, and of arterial nemogroum (op(0)) and pare (motion conditions, and for patients who are well or poorly perfused in hospitals, hospital-type facilities, mobile, and home environments.
0304
Prescription Use _____________________________________________________________________________________________________________________________________________________________ (Per 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use _ (Per 21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
| Concurrence of CDRH, Office of Device Evaluation (ODE) |
|---|
(Division Sign-Dff) Division of Anesthesiology, General Hospital, Infection Control, Dental Devices
510(k) Number: K041813